998 related articles for article (PubMed ID: 28434642)
1. [Late life depression or prodromal Alzheimer's disease: Which tools for the differential diagnosis?].
Gasser AI; Salamin V; Zumbach S
Encephale; 2018 Feb; 44(1):52-58. PubMed ID: 28434642
[TBL] [Abstract][Full Text] [Related]
2. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
[TBL] [Abstract][Full Text] [Related]
3. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
4. [Clinical presentation of Moroccan cases with Alzheimer's disease].
El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of depression and Alzheimer's disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R).
Rotomskis A; Margevičiūtė R; Germanavičius A; Kaubrys G; Budrys V; Bagdonas A
BMC Neurol; 2015 Apr; 15():57. PubMed ID: 25924912
[TBL] [Abstract][Full Text] [Related]
6. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
[TBL] [Abstract][Full Text] [Related]
7. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.
Devanand DP; Sano M; Tang MX; Taylor S; Gurland BJ; Wilder D; Stern Y; Mayeux R
Arch Gen Psychiatry; 1996 Feb; 53(2):175-82. PubMed ID: 8629893
[TBL] [Abstract][Full Text] [Related]
8. Association of subjective memory complaint and depressive symptoms with objective cognitive functions in prodromal Alzheimer's disease including pre-mild cognitive impairment.
Seo EH; Kim H; Choi KY; Lee KH; Choo IH
J Affect Disord; 2017 Aug; 217():24-28. PubMed ID: 28380342
[TBL] [Abstract][Full Text] [Related]
9. Differential cognitive impairment in subjects with geriatric depression who will develop Alzheimer's disease and other dementias: a retrospective study.
Jean L; Simard M; van Reekum R; Clarke DE
Int Psychogeriatr; 2005 Jun; 17(2):289-301. PubMed ID: 16050437
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
11. Executive functions in clinical and preclinical Alzheimer's disease.
Allain P; Etcharry-Bouyx F; Verny C
Rev Neurol (Paris); 2013 Oct; 169(10):695-708. PubMed ID: 24011643
[TBL] [Abstract][Full Text] [Related]
12. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
13. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
[TBL] [Abstract][Full Text] [Related]
14. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
16. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.
Zubenko GS; Zubenko WN; McPherson S; Spoor E; Marin DB; Farlow MR; Smith GE; Geda YE; Cummings JL; Petersen RC; Sunderland T
Am J Psychiatry; 2003 May; 160(5):857-66. PubMed ID: 12727688
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological correlates of apathy in mild cognitive impairment and Alzheimer's disease: the role of executive functioning.
Drijgers RL; Verhey FR; Leentjens AF; Köhler S; Aalten P
Int Psychogeriatr; 2011 Oct; 23(8):1327-33. PubMed ID: 21729413
[TBL] [Abstract][Full Text] [Related]
18. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
